Poland · Delayed Price · Currency is PLN Medicofarma Biotech Statistics
Total Valuation
WSE:MDB has a market cap or net worth of PLN 30.59 million. The enterprise value is 34.50 million.
| Market Cap | 30.59M |
| Enterprise Value | 34.50M |
Important Dates
The next confirmed earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:MDB has 67.98 million shares outstanding.
| Current Share Class | 67.98M |
| Shares Outstanding | 67.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 696.82 |
| PB Ratio | 5.99 |
| P/TBV Ratio | 6.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.77.
| Current Ratio | 0.89 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.50 |
Financial Efficiency
Return on equity (ROE) is -36.93% and return on invested capital (ROIC) is -16.84%.
| Return on Equity (ROE) | -36.93% |
| Return on Assets (ROA) | -6.83% |
| Return on Invested Capital (ROIC) | -16.84% |
| Return on Capital Employed (ROCE) | -16.82% |
| Weighted Average Cost of Capital (WACC) | 9.28% |
| Revenue Per Employee | 6,271 |
| Profits Per Employee | -297,018 |
| Employee Count | 7 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.81% in the last 52 weeks. The beta is 0.84, so WSE:MDB's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +69.81% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 47.84 |
| Average Volume (20 Days) | 37,723 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:MDB had revenue of PLN 43,900 and -2.08 million in losses. Loss per share was -0.03.
| Revenue | 43,900 |
| Gross Profit | -969,115 |
| Operating Income | -1.55M |
| Pretax Income | -2.08M |
| Net Income | -2.08M |
| EBITDA | -56,636 |
| EBIT | -1.55M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1,929 in cash and 3.91 million in debt, with a net cash position of -3.91 million or -0.06 per share.
| Cash & Cash Equivalents | 1,929 |
| Total Debt | 3.91M |
| Net Cash | -3.91M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | 5.11M |
| Book Value Per Share | 0.08 |
| Working Capital | -523,532 |
Cash Flow
| Operating Cash Flow | -940,209 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | 940,400 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,529.54% |
| Pretax Margin | -4,736.04% |
| Profit Margin | n/a |
| EBITDA Margin | -129.01% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WSE:MDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 8, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
WSE:MDB has an Altman Z-Score of 0.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.53 |
| Piotroski F-Score | 2 |